Lisata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LSTA and other ETFs, options, and stocks.About LSTA
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors.
CEODavid J. Mazzo
CEODavid J. Mazzo
Employees26
Employees26
HeadquartersBasking Ridge, New Jersey
HeadquartersBasking Ridge, New Jersey
Founded1980
Founded1980
Employees26
Employees26
LSTA Key Statistics
Market cap18.08M
Market cap18.08M
Price-Earnings ratio-0.97
Price-Earnings ratio-0.97
Dividend yield—
Dividend yield—
Average volume46.47K
Average volume46.47K
High today$2.12
High today$2.12
Low today$1.94
Low today$1.94
Open price$2.01
Open price$2.01
Volume52.97K
Volume52.97K
52 Week high$4.11
52 Week high$4.11
52 Week low$1.81
52 Week low$1.81
Stock Snapshot
Lisata Therapeutics(LSTA) stock is priced at $2.06, giving the company a market capitalization of 18.08M. It carries a P/E multiple of -0.97.
On 2026-01-09, Lisata Therapeutics(LSTA) stock moved within a range of $1.94 to $2.12. With shares now at $2.06, the stock is trading +6.2% above its intraday low and -2.8% below the session's peak.
Trading volume for Lisata Therapeutics(LSTA) stock has reached 52.97K, versus its average volume of 46.47K.
Over the past 52 weeks, Lisata Therapeutics(LSTA) stock has traded between a high of $4.11 and a low of $1.81.
Over the past 52 weeks, Lisata Therapeutics(LSTA) stock has traded between a high of $4.11 and a low of $1.81.
People also own
Based on the portfolios of people who own LSTA. This list is generated using Robinhood data, and it’s not a recommendation.